These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10195068)

  • 1. Augmentation therapy for severe alpha 1-antitrypsin deficiency: is the jury still out on a trial?
    Stoller JK
    Thorax; 1998 Dec; 53(12):1007-9. PubMed ID: 10195068
    [No Abstract]   [Full Text] [Related]  

  • 2. Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.
    McElvaney NG
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S191-6. PubMed ID: 27115956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1 antitrypsin augmentation for alpha 1 antitrypsin deficiency associated lung disease.
    Glaister P; Hindle Robinson N; Ward A; Bentham C; Crossingham I
    Cochrane Database Syst Rev; 2024 Oct; 10(10):CD015930. PubMed ID: 39412060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation therapy for alpha(1)-antitrypsin deficiency.
    Juvelekian GS; Stoller JK
    Drugs; 2004; 64(16):1743-56. PubMed ID: 15301559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-1-antitrypsin replacement therapy: will its efficacy ever be proved?
    Hutchison DC; Hughes MD
    Eur Respir J; 1997 Oct; 10(10):2191-3. PubMed ID: 9387938
    [No Abstract]   [Full Text] [Related]  

  • 6. Alpha-1 antitrypsin augmentation therapy and biomarkers of elastin degradation.
    Ma S; Lin YY; He J; Rouhani FN; Brantly M; Turino GM
    COPD; 2013 Aug; 10(4):473-81. PubMed ID: 23560990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation therapy in alpha(1)-antitrypsin deficiency.
    Burdon JG; Brenton S; Ayad M; Knight K
    Chest; 2001 Aug; 120(2):687. PubMed ID: 11502686
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous alpha-1 antitrypsin augmentation therapy: systematic review.
    Gøtzsche PC; Johansen HK
    Dan Med Bull; 2010 Sep; 57(9):A4175. PubMed ID: 20816015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation therapy in alpha-1 antitrypsin deficiency.
    Sandhaus RA
    COPD; 2009 Jun; 6(3):147-8. PubMed ID: 19811367
    [No Abstract]   [Full Text] [Related]  

  • 11. Trials and Tribulations: An Industry Perspective on Conducting Registrational Trials in Alpha-1 Antitrypsin Deficiency.
    Forshag MS
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S374-7. PubMed ID: 27564675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-1-antitrypsin augmentation treatment: does one size fit all?
    Stolk J
    Thorax; 2006 Dec; 61(12):1034. PubMed ID: 17114371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation therapy for alpha-1 antitrypsin deficiency--not enough evidence to support its use yet!
    McCarthy C; Dimitrov BD
    COPD; 2010 Jun; 7(3):234; author reply 235-6. PubMed ID: 20486824
    [No Abstract]   [Full Text] [Related]  

  • 14. Augmentation therapy of alpha-1 antitrypsin deficiency associated emphysema.
    Traclet J; Delaval P; Terrioux P; Mornex JF
    Rev Mal Respir; 2015 Apr; 32(4):435-46. PubMed ID: 25908241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of a clinical trial of augmentation therapy for alpha(1)-antitrypsin deficiency. The Alpha 1-Antitrypsin Deficiency Registry Study Group.
    Schluchter MD; Stoller JK; Barker AF; Buist AS; Crystal RG; Donohue JF; Fallat RJ; Turino GM; Vreim CE; Wu MC
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):796-801. PubMed ID: 10712324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical utility of alpha-1 proteinase inhibitor in the management of adult patients with severe alpha-1 antitrypsin deficiency: a review of the current literature.
    Parr DG; Lara B
    Drug Des Devel Ther; 2017; 11():2149-2162. PubMed ID: 28769553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-1 antitrypsin augmentation therapy.
    Wewers MD; Crystal RG
    COPD; 2013 Mar; 10 Suppl 1():64-7. PubMed ID: 23527997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of augmentation therapy for emphysema associated with α1-antitrypsin deficiency: enough is enough.
    Balbi B; Ferrarotti I; Miravitlles M
    Eur Respir J; 2016 Jan; 47(1):35-8. PubMed ID: 26721962
    [No Abstract]   [Full Text] [Related]  

  • 19. Reflections from the field regarding the clinical commentary for augmentation therapy in the MZ phenotype.
    Reddy SP; Zaremba M
    Chest; 2009 Apr; 135(4):1109-1110. PubMed ID: 19349412
    [No Abstract]   [Full Text] [Related]  

  • 20. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.